Clinical risk factors predicting genital fungal infections with sodium–glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit
| Date first appeared online | 29/06/2017 |
| DOI | 10.1016/j.pcd.2017.06.004 |
| Authors | Bain S. |
| Journal Name | Primary Care Diabetes |
| Volume |
Documents
- Thong2017.pdf , Book, Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).